Welcome to our dedicated page for Corning news (Ticker: GLW), a resource for investors and traders seeking the latest updates and insights on Corning stock.
Corning Incorporated develops glass, ceramic, and optical-physics technologies for optical communications, mobile consumer electronics, display, automotive, solar, semiconductor, and life sciences markets. News about GLW commonly covers earnings releases, dividend declarations, investor-event updates, and the company’s Springboard plan and Market-Access Platforms.
Recurring product and customer developments include optical fiber, cable, connectors, co-packaged optics, and high-density connectivity for AI data centers; Gorilla Glass and glass-ceramic cover materials for mobile devices; and manufacturing or technology partnerships tied to advanced materials and optical infrastructure.
Corning (GLW) and EnerSys (ENS) announced a strategic collaboration to accelerate 5G deployment by simplifying fiber and electrical power delivery to small-cell sites. The partnership aims to address infrastructure challenges impacting the deployment of outdoor small cells by improving power accessibility and fiber connectivity. This collaboration is expected to enhance operational efficiency, lower installation costs, and expedite service availability, positioning Corning to leverage 5G as a key growth driver in its Optical Communications business.
CORNING, NY, June 09, 2020 – Corning (GLW) announced a $204 million agreement with BARDA to enhance the production of Valor Glass vials for COVID-19 vaccines and treatments. This funding will enable Corning to expand manufacturing capacity in its facilities across New York, North Carolina, and New Jersey, addressing supply chain challenges in the pharmaceutical industry. CEO Wendell P. Weeks emphasized the significance of Valor Glass in ensuring high-quality pharmaceutical packaging, which is crucial for timely vaccine and drug delivery during the pandemic.
Corning Incorporated (NYSE: GLW) and Pfizer Inc. (NYSE: PFE) announced a long-term agreement for the supply of Corning Valor Glass vials for Pfizer's drug products, pending regulatory approval. The collaboration aims to enhance pharmaceutical packaging quality and efficiency, with Valor Glass designed to resist breakage and contamination. It has been provisionally evaluated by the FDA. Both companies believe this partnership will improve biopharmaceutical product quality across the industry.
Summary not available.
Summary not available.
Summary not available.